Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 261

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 2
Chunk 261
---
 1.24 1.55 1.18 4.74 3.70 4.49 3.41 Special itemsStrategic optimization program0.82 0.63 — — 2.10 1.59 — — Integration and transaction-related costs0.03 0.02 0.27 0.21 1.10 0.84 0.62 0.48 (Gain) loss on sale of businesses (0.14)(0.90)0.31 0.22 (0.29)(1.32)0.37 0.07 (Benefits) associated with litigation matters(0.06)(0.05)— — (0.06)(0.05)— — Deferred tax expenses, net (2)— 0.07 — 0.15 — 0.20 — 0.26 Impairment of dividend receivable — — 0.65 0.49 — — 0.64 0.48 Total special items$0.65 (0.23)$1.23 1.07 $2.85 1.26 $1.63 1.29 Adjusted income from operations$7.83 $7.51 $21.76 $20.68 

(1) Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.

(2) Represents amortization of a foreign tax attribute. See Note 20 to the Consolidated Financial Statements in our 2024 Form 10-K for additional details.

37

Financial highlights by segmentThree Months Ended September 30,Nine Months Ended September 30,(Dollars in millions, except per share amounts)20252024Change20252024ChangeRevenuesAdjusted revenues by segmentEvernorth Health Services$60,391 $52,637 15 %$171,897 $148,411 16 %Cigna Healthcare10,755 13,163 (18)35,991 39,583 (9)Other Operations162 234 (31)521 627 (17